- Home
- BZFD vs PRLD Comparison
BZFD vs PRLD Comparison
Compare BZFD & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZFD | PRLD |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.1M | 69.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BZFD | PRLD |
|---|---|---|
| Price | $0.94 | $1.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 471.5K | ★ 3.7M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $184,927,000.00 | $10,500,000.00 |
| Revenue This Year | $6.87 | N/A |
| Revenue Next Year | $6.21 | N/A |
| P/E Ratio | $331.54 | ★ N/A |
| Revenue Growth | N/A | ★ 250.00 |
| 52 Week Low | $0.84 | $0.61 |
| 52 Week High | $5.68 | $4.22 |
Technical Indicators
Market Signals| Indicator | BZFD | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 27.15 | 52.40 |
| Support Level | $0.84 | $1.32 |
| Resistance Level | $0.99 | $1.69 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 32.55 | 91.02 |
Price Performance
Historical ComparisonAbout BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.